Onto Innovation
ONTO
$203.62
-2.89%
Onto Innovation Inc. designs, manufactures, and supports high-performance process control metrology, defect inspection, lithography, and data-analytics systems used by microelectronics manufacturers, operating within the semiconductor capital equipment industry. The company occupies a specialized niche as a supplier of yield-critical inspection and metrology tools — a position that makes it a key enabler rather than a broad-line equipment vendor, with revenue concentrated in Taiwan and South Korea where leading-edge foundry and memory customers operate. The current investor narrative centers on Onto's exposure to advanced packaging and AI-chip production, with recent headlines highlighting raised guidance, a record backlog, and a Q3 revenue beat featuring roughly 88% year-over-year growth, alongside a strategic partnership seen as a potential growth catalyst. That bullish fundamental story is being vigorously debated against a brutal share-price drawdown, as investors question the durability of the growth trajectory and whether the stock's 41% decline reflects a genuine deterioration in forward demand or an overreaction to cyclical semiconductor capex concerns.…
ONTO
Onto Innovation
$203.62
Related headlines
Investment Opinion: Should I buy ONTO Today?
Rating: Buy (accumulate), with position sizing discipline. The thesis in one sentence: ONTO is a high-growth, near-debt-free metrology and inspection enabler for advanced packaging and AI-chip production whose fundamentals (35.3% YoY revenue growth, gross margin up from 46.4% to 53.4% in two quarters, $252.47M TTM free cash flow) have decoupled from a 41% sentiment-driven drawdown, and the unanimous 12-Buy consensus with a $336.08 average target (+56% from $215.06) anchors a favorable risk/reward for investors who can tolerate the volatility. The rating is grounded in the analyst consensus of strong_buy (recommendation mean 1.25) and an average target implying roughly 56% upside, with even the $240 low target sitting about 12% above the current price.
Supporting evidence is unusually concrete for a stock in a downtrend. First, valuation: the forward PE of 16.72x on consensus EPS of $22.02 is near the low end of the stock's historical band, and the 8.11x PS (7.56x EV/Sales) is far below the 54.5x peak reached at Q2 2026, even though absolute multiples like 35.01x EV/EBITDA remain at the high end of the semiconductor equipment peer group. Second, growth: revenue climbed sequentially from $218.19M (Q3 2025) to $266.87M, $291.95M, and $343.13M (Q2 2026), a 35.3% YoY rate, with recent coverage citing an 87.8% Q3 revenue beat, raised guidance, and a record backlog. Third, profitability: gross margin expanded from 46.39% to 50.14% to 53.41% and operating margin from 5.19% to 13.26% to 18.52% across the last three quarters, lifting net income from $10.53M to $60.10M. Fourth, balance sheet and cash: debt-to-equity of 0.0083, a 5.79 current ratio, $1.25B of cash, and $252.47M of TTM free cash flow on only $3.66M of quarterly capex mean the growth is self-funded and there is no solvency risk to discount.
The biggest risks that could invalidate the thesis are (1) the forward EPS of $22.02 proving unreachable if advanced packaging orders roll over, which would leave the 59.67x trailing PE as the true anchor; (2) revenue concentration — Systems and Software was $294.04M of the $343.13M total versus $28.71M in Parts and $20.38M in Service, with revenue concentrated in Taiwan and South Korea foundry and memory capex budgets; and (3) a high beta of 1.682 that has already produced a 58.78% max drawdown and 36.34% three-month underperformance versus SPY. The rating would upgrade to a higher-conviction Buy if the stock reclaims the $250-$270 resistance band while forward estimates hold, and would downgrade to Hold if Q4 revenue growth decelerates below roughly 20% YoY or if any of the 12 Buy ratings is cut. On balance the stock looks fairly valued to modestly undervalued relative to its own history (8.11x PS near the low end of a 12x-54.5x band) but still premium versus peers on absolute EV/EBITDA — a data-driven verdict, not personalized financial advice.
Sign up to view all
ONTO 12-Month Price Forecast
The forward view is bullish but not high-conviction, because the fundamental data (35.3% revenue growth, 53.41% gross margin, $252.47M TTM free cash flow, 0.0083 debt-to-equity) is measurably strong while the price action (58.78% max drawdown, 36.34% three-month underperformance versus SPY, 1.682 beta) reflects a sentiment unwind rather than reported deterioration. The entire thesis hinges on the $22.02 forward EPS: at 16.72x forward earnings the stock is cheap, but at 59.67x trailing earnings it is still expensive, so estimate revisions are the single variable that matters most. The $210 spread between the $240 low and $450 high analyst targets, combined with unanimous Buy ratings that predate the worst of the decline, argues for medium rather than high confidence. I would upgrade to high confidence if the stock reclaims the $250-$270 resistance band on volume while forward estimates hold, and would downgrade to neutral if Q4 revenue growth decelerates below 20% YoY or the first analyst downgrade appears.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Onto Innovation's 12-month outlook, with a consensus price target around $329.00 and implied upside of +61.6% versus the current price.
Average Target
$329.00
12 analysts
Implied Upside
+61.6%
vs. current price
Analyst Count
12
covering this stock
Price Range
$240 - $450
Analyst target range
Coverage is robust with 12 analysts, all of whom are bullish: 12 Buy ratings, 0 Hold, and 0 Sell, producing a consensus recommendation of "strong_buy" with a recommendation mean of 1.25. The average target price is $336.08, which implies roughly +56% upside from the current price of $215.06 — a strikingly bullish consensus given the stock's recent collapse. The consensus clearly leans strongly bullish, and the uniformity of Buy ratings (no Holds or Sells) signals high conviction among covering analysts, though such one-sided sentiment can also reflect lagging ratings that have not yet been updated for the recent drawdown. The target range is wide, from a low of $240.00 to a high of $450.00, a spread of $210 (roughly 88% of the current price), which signals meaningful uncertainty about the growth trajectory. The high target of $450 likely assumes multiple expansion and sustained acceleration in advanced packaging and AI-driven demand, consistent with the raised guidance and record backlog cited in recent coverage; the low target of $240 still implies about 12% upside and likely prices in some margin normalization or cyclical caution. Institutional ratings show a pattern of reaffirmations rather than upgrades or downgrades — Morgan Stanley reiterated Overweight on September 8, 2026, and Needham, Jefferies, and Evercore ISI all reiterated Buy/Outperform ratings on August 7, 2026 — suggesting analysts are holding their bullish stance through the volatility rather than capitulating. The wide target spread combined with unanimous Buy ratings and a 41% stock decline creates a notable disconnect: either the market is mispricing a high-conviction growth story, or analysts are lagging the deterioration in forward demand.
Bulls vs Bears: ONTO Investment Factors
The bull case rests on genuinely powerful fundamentals: 35.3% YoY revenue growth, gross margins expanding from 46.4% to 53.4% in two quarters, a near-debt-free balance sheet with $1.25B in cash, and unanimous analyst Buy ratings with a $336.08 average target implying 56% upside. The bear case rests on price action and valuation: a 58.78% max drawdown, 36.34% three-month underperformance versus SPY, a 1.682 beta, and absolute multiples (8.11x PS, 35.01x EV/EBITDA) that remain rich even after the collapse. On balance, the fundamental evidence is currently stronger than the technical evidence, because the operating data is measured and reported while the selloff reflects sentiment and cyclical fear rather than any reported deterioration. The single most important tension is whether the forward EPS estimate of $22.02 is achievable: if earnings triple as consensus expects, the 16.72x forward PE is cheap and the stock is mispriced; if advanced packaging demand rolls over and estimates are cut, the trailing 59.67x PE becomes the true anchor and the shares are still expensive.
Bullish
- Revenue re-accelerating at 35% YoY: Q2 2026 revenue of $343.13M rose 35.3% YoY from $253.60M, and the sequential climb from $218.19M (Q3 2025) to $266.87M, $291.95M, and $343.13M shows a clear re-acceleration. Recent coverage cites roughly 88% YoY growth in the latest Q3 report, reinforcing that demand for advanced packaging and AI-chip inspection tools is inflecting rather than fading.
- Rapid margin expansion: Gross margin expanded from 46.39% in Q4 2025 to 50.14% in Q1 2026 and 53.41% in Q2 2026, while operating margin jumped from 5.19% to 13.26% to 18.52% over the same quarters. Net income rose from $10.53M (3.9% margin) in Q4 2025 to $60.10M (17.5% margin) in Q2 2026, showing operating leverage kicking in as volumes scale.
- Pristine balance sheet, strong FCF: Debt-to-equity is just 0.0083 and the current ratio is 5.79, with $1.25B of cash at the end of Q2 2026. Free cash flow TTM is $252.47M on only $3.66M of quarterly capex, an asset-light model that funds growth without leverage risk.
- Unanimous analyst conviction, 56% upside: All 12 covering analysts rate ONTO a Buy (recommendation mean 1.25, consensus strong_buy), with an average target of $336.08 implying roughly +56% upside from $215.06. Even the low target of $240 implies about 12% upside, meaning the Street sees downside as limited relative to current levels.
Bearish
- Violent downtrend, broken momentum: The stock is down 21.44% over one month and 36.34% over three months, with a 58.78% max drawdown from its peak near $386.46. It trades at roughly 35% of its 52-week range and has underperformed SPY by 34.02% over three months, signaling a momentum unwind rather than a simple pullback.
- Valuation still rich on absolute basis: Despite the selloff, the stock trades at 8.11x sales, 35.01x EV/EBITDA, and 59.67x trailing PE, multiples that sit at the high end of the semiconductor equipment peer group. The forward PE of 16.72x depends entirely on earnings roughly tripling to the $22.02 consensus EPS, leaving little room for execution error.
- Cyclical, equipment-heavy revenue mix: Systems and Software Revenue of $294.04M dominates the $343.13M quarterly total versus just $28.71M in Parts and $20.38M in Service, meaning growth is driven by cyclical equipment sales rather than recurring revenue. Revenue is also concentrated in Taiwan and South Korea, exposing results to a narrow set of foundry and memory capex budgets.
- High beta amplifies drawdowns: A beta of 1.682 makes ONTO roughly 68% more volatile than the market, and the 58.78% max drawdown is a direct manifestation of that leverage to sector sentiment. In a semiconductor capex downturn, the stock could fall far harder than the broader market, as the recent 36% three-month decline demonstrates.
ONTO Technical Analysis
Onto is in a violent, high-volatility downtrend despite still-positive long-term returns, with the stock up 61.17% over the past year but trading at roughly 35% of its 52-week range (current price $215.06 versus a 52-week low of $121.58 and high of $386.46). That positioning — closer to the lows than the highs after a peak near $386 — signals a broken uptrend and a market that has aggressively de-rated the shares, even though the 1-year gain remains intact. The 58.78% max drawdown underscores how severe the reversal has been from the summer highs. Recent momentum is decisively negative and diverging sharply from the longer-term trend: the stock is down 21.44% over the past month and 36.34% over three months, versus a 1-year gain of 61.17% and a YTD gain of 29.66%. This divergence — strong annual performance but collapsing intermediate momentum — is characteristic of a momentum unwind or mean-reversion event rather than a simple pullback, and the relative strength figures confirm the underperformance, with -19.09% versus SPY over one month and -34.02% over three months. Notably, the most recent session showed a sharp +8.89% bounce off the $155.99 low (November 5), suggesting buyers are stepping in near capitulation levels, though one day does not reverse a downtrend. Key levels are well defined: support sits at the $155.99 recent low and the $121.58 52-week low, while resistance lies at the $386.46 52-week high with intermediate supply near $250-$270 where prior support broke down. A breakout above $250-$270 would signal trend repair, while a breakdown below $155.99 would confirm the downtrend and open the door toward the 52-week low. With a beta of 1.682, the stock is roughly 68% more volatile than the market, meaning position sizing must account for amplified drawdowns — the 58.78% max drawdown is a direct manifestation of that leverage to market and sector sentiment.
Beta
1.68
1.68x market volatility
Max Drawdown
-58.8%
Largest decline past year
52-Week Range
$122-$386
Price range past year
Annual Return
+57.0%
Cumulative gain past year
| Period | ONTO Return | S&P 500 |
|---|---|---|
| 1m | -15.7% | -2.3% |
| 3m | -38.6% | -2.8% |
| 6m | -25.1% | +2.1% |
| 1y | +57.0% | +12.3% |
| ytd | +22.8% | +10.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ONTO Fundamental Analysis
Revenue is accelerating powerfully, with the most recent quarter (Q2 2026, ended June 30) delivering $343.13 million, up 35.3% year over year from $253.60 million in Q2 2025, and up sequentially from $291.95 million in Q1 2026 and $266.87 million in Q4 2025. The multi-quarter trend is clearly one of re-acceleration: revenue rose from $218.19 million in Q3 2025 to $266.87 million in Q4 2025, $291.95 million in Q1 2026, and $343.13 million in Q2 2026 — a steady climb that supports the bullish narrative around advanced packaging and AI-driven demand. Segment data shows Systems and Software Revenue at $294.04 million dominating the mix, with Parts Revenue at $28.71 million and Service Revenue at $20.38 million, meaning the growth is being driven by equipment sales rather than recurring revenue — a higher-beta, more cyclical growth profile. Profitability is solid and improving: Q2 2026 net income was $60.10 million (17.5% net margin) on a 53.41% gross margin, up from $33.75 million (11.6% margin) in Q1 2026 and $10.53 million (3.9% margin) in Q4 2025. Gross margin expanded from 46.39% in Q4 2025 to 50.14% in Q1 2026 and 53.41% in Q2 2026, while operating margin rose from 5.19% to 13.26% to 18.52% over the same quarters — a clear margin-expansion story. The balance sheet is exceptionally strong: debt-to-equity is just 0.0083, the current ratio is 5.79, and cash at end of Q2 2026 was $1.25 billion, giving the company ample liquidity and essentially no leverage risk. Free cash flow TTM is $252.47 million, and Q2 2026 free cash flow was $57.85 million on operating cash flow of $61.51 million, with capex of only $3.66 million — a very asset-light model. ROE of 6.51% and ROA of 6.21% look modest, but that reflects the depressed trailing earnings base and the recent acquisition-related balance sheet expansion rather than underlying cash generation weakness.
Quarterly Revenue
$409748000.0B
2026-09
Revenue YoY Growth
+87.8%
YoY Comparison
Gross Margin
54.8%
Latest Quarter
Free Cash Flow
$247643000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ONTO Overvalued?
Because net income is positive ($60.10 million in Q2 2026), the PE ratio is the appropriate primary metric, and the trailing PE of 59.67x stands in stark contrast to the forward PE of 16.72x — a gap that implies the market expects earnings to roughly triple over the next year. That forward multiple is consistent with the analyst consensus EPS estimate of $22.02, which would represent an enormous step-up from the current trailing EPS of $0.0168 (a figure distorted by the trailing calculation methodology), so the forward PE is the more meaningful anchor here. On a price-to-sales basis, the stock trades at 8.11x (EV/Sales of 7.56x), and EV/EBITDA is 35.01x — rich absolute multiples that reflect the market's growth expectations. Peer comparison within semiconductors is limited by the absence of a clean industry-average dataset, but the 8.11x PS and 35.01x EV/EBITDA sit at the higher end of the semiconductor equipment peer group, consistent with a premium for above-market growth (35.3% YoY revenue). The premium appears justified by the margin expansion and near-zero leverage, though it leaves little room for execution error. Historically, the stock's PS ratio has ranged widely — from roughly 12x-13x in 2022 to 54.5x at the Q2 2026 peak — and the current 8.11x PS is near the low end of that multi-year band, suggesting the recent selloff has compressed valuation to a more reasonable level. The trailing PE of 59.67x is elevated versus the 2022-2023 range of roughly 12x-62x, but the forward PE of 16.72x is near the low end of the historical band, implying the market is pricing in optimistic forward earnings while the trailing multiple looks stretched — a classic setup where the valuation debate hinges entirely on whether forward estimates are achievable.
PE
59.7x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 13x~80x
vs. Industry Avg
54.4x
Industry PE ~54.4x*
EV/EBITDA
35.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on the cyclicality of an equipment-led revenue mix and the dependence on continued growth to justify valuation. Systems and Software Revenue of $294.04M accounted for roughly 86% of Q2 2026's $343.13M total versus only $28.71M in Parts and $20.38M in Service, so results hinge on capital equipment orders rather than recurring revenue. Revenue is concentrated in Taiwan and South Korea, exposing the company to a narrow set of foundry and memory capex budgets, and the forward PE of 16.72x assumes EPS roughly triples to $22.02 from a trailing base distorted at $0.0168. Balance-sheet risk is minimal with debt-to-equity of 0.0083, a 5.79 current ratio, and $1.25B in cash, but earnings volatility is high: net income swung from $10.53M in Q4 2025 to $60.10M in Q2 2026, and ROE of 6.51% remains modest relative to the valuation.
Market and competitive risks are dominated by valuation compression and high beta. At 8.11x sales, 35.01x EV/EBITDA, and 59.67x trailing PE, ONTO trades at the high end of the semiconductor equipment peer group, leaving little cushion if growth expectations reset. A beta of 1.682 means the stock is roughly 68% more volatile than the market, and the 58.78% max drawdown shows how violently that leverage plays out when sector sentiment turns. Recent news captures the debate directly: one outlet calls the stock a hold after a 41% decline despite an 87.8% Q3 revenue beat, while others highlight raised guidance and a record backlog as a compelling buy, illustrating how quickly the narrative can flip on cyclical capex concerns.
The worst-case scenario is a semiconductor capex downturn combined with estimate cuts: advanced packaging orders slow, the $22.02 forward EPS proves unreachable, and analysts capitulate from their unanimous Buy stance, compressing the multiple toward the low end of its historical band. In that chain, the stock would retest the November 5 low of $155.99 (about -27% from $215.06) and potentially the 52-week low of $121.58 (about -43%). The analyst low target of $240 offers little protection since it sits above the current price, so the realistic downside is a -27% to -43% move, consistent with the 58.78% max drawdown already realized this year.
FAQ
Ranked by severity: first, estimate risk — the 16.72x forward PE rests on EPS reaching $22.02, and if advanced packaging demand slows and estimates are cut, the 59.67x trailing PE becomes the anchor and the stock is expensive again. Second, cyclical and concentration risk — Systems and Software Revenue of $294.04M was roughly 86% of the $343.13M Q2 2026 total versus $28.71M in Parts and $20.38M in Service, and revenue is concentrated in Taiwan and South Korea foundry and memory capex budgets, so a single customer region's capex cut hits hard. Third, volatility and momentum risk — a beta of 1.682, a 58.78% max drawdown, and 36.34% three-month underperformance versus SPY mean the stock can fall far harder than the market, and the unanimous 12-Buy consensus may be lagging rather than leading. Fourth, valuation compression risk — at 35.01x EV/EBITDA and 8.11x sales, any sector rotation away from semiconductor equipment would de-rate the multiple even if earnings hold. Financial solvency risk is minimal given $1.25B cash and a 5.79 current ratio.
The 12-month forecast splits into three scenarios. The base case (50% probability, $240-$336) assumes revenue tracks the $3.10B-$3.45B consensus, gross margin holds near 53.41%, and EPS lands in the $20.48-$23.51 band, letting the stock grind back toward the $336.08 average target as the drawdown proves an overreaction. The bull case (30% probability, $336-$450) requires advanced packaging and AI inspection demand to compound, the record backlog to convert near the $3.28B consensus, and multiple re-rating toward the $450 high target. The bear case (20% probability, $156-$240) assumes a capex downturn, unreachable $22.02 EPS, estimate cuts, and a retest of the $155.99 low with risk toward $121.58. The base case is most likely, and its key assumption is that forward EPS estimates hold — that single variable determines whether the stock is cheap or expensive.
The answer depends entirely on which earnings base you trust. On trailing figures the stock looks expensive at 59.67x PE, 8.11x PS, 7.56x EV/Sales, and 35.01x EV/EBITDA — multiples at the high end of the semiconductor equipment peer group. On forward figures it looks cheap: 16.72x the $22.02 consensus EPS, near the low end of the stock's historical band, and the 8.11x PS is far below the 54.5x peak reached at Q2 2026 and even below the 12x-13x range seen in 2022. The market is therefore pricing in a large earnings step-up — roughly a tripling of earnings — and the current price embeds skepticism that it will be delivered. Relative to its own history the stock is modestly undervalued after a 41% drawdown; relative to peers on absolute EV/EBITDA it still carries a premium. The verdict is fairly valued to modestly undervalued on forward numbers, contingent on estimate delivery.
From a risk/reward standpoint the setup is asymmetric but volatile: the $336.08 average analyst target implies roughly +56% upside from $215.06, and even the $240 low target sits about 12% above the current price, while the realistic downside is a retest of the $155.99 November 5 low (about -27%) or the $121.58 52-week low (about -43%). The fundamental case is concrete — 35.3% YoY revenue growth, gross margin up from 46.39% to 53.41% in two quarters, $252.47M TTM free cash flow, and debt-to-equity of just 0.0083 — but the valuation is only attractive on forward numbers: 16.72x forward PE versus 59.67x trailing. The biggest downside risk is that the $22.02 consensus EPS proves unreachable if advanced packaging orders roll over, which would leave the trailing multiple as the true anchor. It is a good buy for growth-oriented investors with a multi-year horizon who can tolerate a 1.682 beta and a 58.78% max drawdown, ideally accumulated in tranches near support rather than chased after the recent +8.89% single-day bounce. It is not a good buy for capital-preservation or income-focused investors, given the zero dividend and cyclical equipment exposure.
ONTO is structurally a long-term holding but tactically a difficult short-term trade. The long-term case rests on a genuine secular driver — advanced packaging and AI-chip inspection — plus a self-funded, asset-light model ($252.47M TTM free cash flow on only $3.66M quarterly capex) and a pristine balance sheet ($1.25B cash, 0.0083 debt-to-equity), which supports a multi-year compounding thesis if the $22.02 forward EPS trajectory materializes. The short-term picture is hostile: a 1.682 beta, a 58.78% max drawdown, -21.44% one-month and -36.34% three-month returns, and a broken uptrend with resistance at $250-$270 make timing treacherous, and the zero dividend (payout ratio 0) means there is no income to cushion the wait. Earnings visibility is moderate — consensus revenue of $3.28B and a record backlog help, but the equipment cycle is inherently lumpy. A suggested minimum holding period is 18-24 months, entered in tranches, with a review trigger if Q4 revenue growth decelerates below ~20% YoY or the first analyst downgrade appears.

